Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

B Braun buys McGaw for $320 million:

This article was originally published in Clinica

German company B Braun Melsungen has bought Ivax subsidiary McGaw, which makes intravenous solutions and related products, for around $320 million. B Braun will make additional payments of up to $80 million, depending on the operating results of McGaw and B Braun's US subsidiary. US company Ivax will receive royalties based on B Braun and McGaw's commercialisation of Duplex, a multi-compartment drug-delivery system designed for intravenous drugs that have limited stability after mixing.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT084956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel